Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Conventional Therapy for Chronic Venous Leg Ulcers
NCT05974982Phase 1Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Sep 2022
- Primary completion
- May 2023
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of platelet-rich plasma in venous leg ulcer (VLU) (2 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoints: Complete healing at 9 months, Length of ulcer at 9 months and 1 more. Started Sep 2022; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT05974982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05974982.